IFP Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

IFP Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,450	Closed	-$21K	–	4411
2017 Q1	$21K	Hold	4,450	–	–	﹤0.01%	2498
2016 Q4	$22K	Buy	+4,450	New	+$22.8K	﹤0.01%	2409

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

IFP Advisors's OSIR Position: Q2 2017 in Review

IFP Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 4,450 shares — an estimated $21K sold.

IFP Advisors first reported a position in OSIR in Q4 2016 and held it in 2 quarters. The position peaked at $22K in Q4 2016. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

IFP Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
IFP Advisors sold 4,450 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $21K.
IFP Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
IFP Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $22K in Q4 2016.
3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on IFP Advisors's 13F filing for Q2 2017, filed 31 Jul 2017.